Table 2

Laboratory findings among patients infected with SARS-CoV-2 admitted to two hospitals in Uganda

CharacteristicAllMulago National Specialised Hospital/−HCQEntebbe Regional Referral Hospital/+HCQP value
Laboratory
 White cell count/mm3n=47n=21n=26
 Median (IQR)5.1 (4.2−6.2)5.0 (4.2−6.3)5.1 (4.5−6.1)0.473*
 Distribution, n (%)
 ≥10 000/mm30 (0.0)0 (0.0)0 (0.0)
 4001−<10 000/mm342 (89.4)17 (81.0)25 (92.1)0.158†
 ≤4000/mm35 (10.6)4 (19.0)1 (3.9)
Neutrophil countn=45n=19n=26
 Median (IQR)/mm32 (2−2)2 (1−2)2 (2−2)0.092*
 Distribution, n (%)
 ≤1500/mm37 (15.6)5 (26.3)2 (7.7)0.114†
Lymphocyte countn=45n=19n=26
 Median (IQR)/mm32.3 (1.8−2.9)2.4 (1.4−2.9)2.3 (2.0−2.9)0.340*
 Distribution, n (%)
 ≤1500/mm35 (11.1)5 (26.3)0 (0.0)0.010†
Platelets per mm3n=19n=18n=1
 Median (IQR)227 (121−275)224.5 (121−275)2320.855*
 Distribution, n (%)
  <150 000/mm35 (26.3)5 (27.8)0 (0.0)>0.999†
Haemoglobin (g/L)n=19n=18n=1
 Median (IQR)1.47 (1.34−1.60)1.47 (1.34−1.57)1.620.273*
 Distribution, n (%)
 ≤1.0 g/L2 (10.5)2 (11.1)0 (0.0)>0.999†
 Aspartate aminotransferase >40 U/L, n/N (%)4/47 (8.5)3/18 (16.7)1/29 (3.5)0.150†
 Alanine aminotransferase >40 U/L, n/N (%)6/47 (12.8)5/18 (27.8)1/29 (3.5)0.025†
 LDH≥250 U/L, n/N (%) lactate0/11 (0.0)0/11 (0.0)
 Creatinine ≥133 μmol/L, n/N (%)0/48 (0.0)0/19 (0.0)0/29 (0.0)
 Troponin, median (IQR)0.1 (0.1–0.1)0.1 (0.1–0.1)0.1 (0.1–0.1)0.532*
 Total bilirubin >17.1 μmol/L, n/N (%)2/15 (13.3)2/14 (14.3)0/1 (0.0)>0.999†
 Total bilirubin, median (IQR)2.5 (0–12.9)2.4 (0–11.7)13.80.232*
 C reactive protein ≥10 mg/L, n/N (%)6/49 (12.2)5/24 (20.8)1/25 (4.0)0.098†
 Median (IQR)1.7 (0.5–8.1)4.0 (1.8–9.7)0.5 (0.5–1.4)<0.001*
Procalcitonin ng/mLn=49n=24n=25
 Median (IQR)0.1 (0.1–0.12)0.1 (0.1–0.12)0.1 (0.1–0.13)0.614*
Lactate dehydrogenasen=49n=24n=25
 Median (IQR)330 (287–402)318 (244–385)330.5 (295.5–402.5)0.282†
  • *Wilcoxon rank-sum test.

  • †Fisher’s exact test.

  • LDH, lactate dehydrogenase.